关注
Leonidas Stamatatos
Leonidas Stamatatos
在 fredhutch.org 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing …
M Li, F Gao, JR Mascola, L Stamatatos, VR Polonis, M Koutsoukos, ...
Journal of virology 79 (16), 10108-10125, 2005
12712005
Rational HIV immunogen design to target specific germline B cell receptors
J Jardine, JP Julien, S Menis, T Ota, O Kalyuzhniy, A McGuire, D Sok, ...
Science 340 (6133), 711-716, 2013
8122013
Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection
DN Sather, J Armann, LK Ching, A Mavrantoni, G Sellhorn, Z Caldwell, ...
Journal of virology 83 (2), 757-769, 2009
6552009
Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?
L Stamatatos, L Morris, DR Burton, JR Mascola
Nature medicine 15 (8), 866-870, 2009
5712009
mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
L Stamatatos, J Czartoski, YH Wan, LJ Homad, V Rubin, H Glantz, ...
Science 372 (6549), 1413-1418, 2021
5482021
Interactions of cationic lipid vesicles with negatively charged phospholipid vesicles and biological membranes
L Stamatatos, R Leventis, MJ Zuckermann, JR Silvius
Biochemistry 27 (11), 3917-3925, 1988
4251988
Characteristics of the earliest cross-neutralizing antibody response to HIV-1
I Mikell, DN Sather, SA Kalams, M Altfeld, G Alter, L Stamatatos
PLoS pathogens 7 (1), e1001251, 2011
4082011
Analysis of a SARS-CoV-2-infected individual reveals development of potent neutralizing antibodies with limited somatic mutation
E Seydoux, LJ Homad, AJ MacCamy, KR Parks, NK Hurlburt, ...
Immunity 53 (1), 98-105. e5, 2020
3952020
Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies
AT McGuire, S Hoot, AM Dreyer, A Lippy, A Stuart, KW Cohen, J Jardine, ...
Journal of Experimental Medicine 210 (4), 655-663, 2013
3522013
Structural repertoire of HIV-1-neutralizing antibodies targeting the CD4 supersite in 14 donors
T Zhou, RM Lynch, L Chen, P Acharya, X Wu, NA Doria-Rose, MG Joyce, ...
Cell 161 (6), 1280-1292, 2015
3212015
Immunization for HIV-1 broadly neutralizing antibodies in human Ig knockin mice
P Dosenovic, L von Boehmer, A Escolano, J Jardine, NT Freund, AD Gitlin, ...
Cell 161 (7), 1505-1515, 2015
3022015
The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following …
SW Barnett, S Lu, I Srivastava, S Cherpelis, A Gettie, J Blanchard, S Wang, ...
Journal of virology 75 (12), 5526-5540, 2001
2912001
Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study
KM Hastie, H Li, D Bedinger, SL Schendel, SM Dennison, K Li, ...
Science 374 (6566), 472-478, 2021
2602021
Computational design of epitope-scaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitope
BE Correia, YEA Ban, MA Holmes, H Xu, K Ellingson, Z Kraft, C Carrico, ...
Structure 18 (9), 1116-1126, 2010
2592010
Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs
S Hoot, AT McGuire, KW Cohen, RK Strong, L Hangartner, F Klein, ...
PLoS pathogens 9 (1), e1003106, 2013
2292013
Induction of HIV neutralizing antibody lineages in mice with diverse precursor repertoires
M Tian, C Cheng, X Chen, H Duan, HL Cheng, M Dao, Z Sheng, M Kimble, ...
Cell 166 (6), 1471-1484. e18, 2016
2242016
N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti …
RA McCaffrey, C Saunders, M Hensel, L Stamatatos
Journal of virology 78 (7), 3279-3295, 2004
2182004
Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor
C Cheng-Mayer, R Liu, NR Landau, L Stamatatos
Journal of virology 71 (2), 1657-1661, 1997
2101997
V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from …
A Ly, L Stamatatos
Journal of virology 74 (15), 6769-6776, 2000
2072000
Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice
AT McGuire, MD Gray, P Dosenovic, AD Gitlin, NT Freund, J Petersen, ...
Nature communications 7 (1), 10618, 2016
1902016
系统目前无法执行此操作,请稍后再试。
文章 1–20